Universe Pharmaceuticals Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Universe Pharmaceuticals Inc in the fourth quarter 2025?
Universe Pharmaceuticals Inc had a negative return on equity (ROE) of -6.54%, due to the net loss of $-3 billion, during the twelve months ending in the fourth quarter 2025.

Within the Major Pharmaceutical Preparations industry 68 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2025 from to 2630.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Sep 30 2023) IV. Quarter
Y / Y Equity Change	23.35 %	209776.27 %	141882.48 %	100.68 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-3,672	-6	-6	-6	-6
Return On Equity (TTM)	-6.54 %	-0.01 %	-0.02 %	-0.02 %	-0.03 %
UPC's Total Ranking	# 2630	#	#	#	#
Equity (TTM) in Millions	56,130	56,130	56,130	56,130	45,503
Seq. Equity Change	0 %	0 %	0 %	23.35 %	170042 %
Seq. Net Income Change	-	-	-	-	-

Back to UPC Management Effectiveness >> UPC's 5 Years Annual ROE >> Compare UPC ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 69
Sector	# 215
Overall	# 2630

Return On Equity Statistics
High	Average	Low
-0.02 %	-6.44 %	-19.18 %
		(Sep 30 2024)

UPC Annual Return On Equity	(Sep 30 2025) 2025	(Sep 30 2024) 2024	(Sep 30 2023) 2023	(Sep 30 2022) 2022	(Sep 30 2021) 2021
Total Equity in Millions	56,130	45,503	27,970	35,331	47
Y / Y Equity Change	23.35 %	62.68 %	-20.83 %	75083.64 %	-
Net Income in Millions	-3,672	-8,727	-6	-9	11
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-6.54 %	-19.18 %	-0.02 %	-0.02 %	24.09 %

Back to UPC Management Effectiveness >> UPC's 5 Years Annual ROE >> Compare UPC ROE to its Competitors

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
UPC's' Return on Equity at Yahoo Finance
UPC's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for UPC's Competitors
Subscribers only: Roe for Universe Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Equity for UPC's Customers

Companies with similar Return On Equity at Sep 30 2025, within Healthcare Sector

ROE

Date modified: 2026-07-07T13:48:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.